BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10443957)

  • 1. Hereditary and acquired antithrombin deficiency.
    Vinazzer H
    Semin Thromb Hemost; 1999; 25(3):257-63. PubMed ID: 10443957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of antithrombin III concentrates].
    Vinazzer H
    Beitr Infusionsther; 1989; 24():151-8. PubMed ID: 2481532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antithrombin III in various conditions in internal medicine].
    Malý J; Pecka M; Pidrman V; Zadák Z; Gregor J; Jebavý L; Bláha M; Siroký O
    Vnitr Lek; 1997 Oct; 43(10):645-8. PubMed ID: 9601877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.
    Rodgers GM
    Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experiences with the substitution of antithrombin III concentrates in congenital and acquired deficiency disorders].
    Schramm W
    Behring Inst Mitt; 1983 Aug; (73):66-78. PubMed ID: 6332613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antithrombin III substitution in patients in shock].
    Vinazzer H; Blauhut B; Bergmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):806-16. PubMed ID: 6083957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acquired antithrombin III deficiency].
    Müller G
    Z Gesamte Inn Med; 1992 Feb; 47(2):74-7. PubMed ID: 1585693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III deficiency: clinical relevance and replacement therapy.
    Gallus AS
    Dev Biol Stand; 1987; 67():59-66. PubMed ID: 3609485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical aspects of acquired antithrombin III deficiency].
    von Blohn G; Hellstern P; Köhler M; Scheffler P; Wenzel E
    Behring Inst Mitt; 1986 Feb; (79):200-15. PubMed ID: 3718407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of antithrombin III.
    Breddin HK; Kirchmaier CM
    Wien Klin Wochenschr; 1984 Dec; 96(24):875-9. PubMed ID: 6528616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
    Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
    Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Substitution of antithrombin III in shock and consumption coagulopathy].
    Blauhut B; Bergmann H; Vinazzer H
    Wien Klin Wochenschr; 1984 Dec; 96(24):879-81. PubMed ID: 6528617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary antithrombin III deficiency: biochemical aspects.
    Sas G
    Haematologia (Budap); 1984; 17(1):81-6. PubMed ID: 6724355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the clinical significance of acquired antithrombin deficiency.
    Sørum Y; Handeland GF; Abildgaard U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):797-805. PubMed ID: 6083956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with AT III concentrates in hereditary and acquired AT III deficiency.
    Gromnica-Ihle E; Ziemer S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):307-13. PubMed ID: 2465221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use of antithrombin III concentrates.
    Vinazzer H
    Vox Sang; 1987; 53(4):193-8. PubMed ID: 3326267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.